Philip Denner

Philip Denner is currently the Head of Laboratory Automation Technologies at DZNE - German Center for Neurodegenerative Diseases since 2011. Previously, Philip worked as a Research Scientist in High Content Screening at Bayer AG from January 2007 to July 2010, focusing on the development of cellular assays to support preclinical drug development.